Stifel Financial’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Stifel Financial's ANIP Position: Q3 2026 in Review
Stifel Financial reduced its ANI Pharmaceuticals (ANIP) stake by 32% in Q3 2026, selling an estimated $255K and leaving 7,153 shares worth $520K. The position accounts for ﹤0.01% of the portfolio, ranked #2961.
Stifel Financial first reported a position in ANIP in Q3 2017 and has held it in 17 quarters since. The position peaked at $867K in Q2 2026. 291 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Stifel Financial held 7,153 shares of ANI Pharmaceuticals worth $520K as of Q3 2026.
- Stifel Financial sold 3,315 ANI Pharmaceuticals shares in Q3 2026, an estimated $255K.
- ANI Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q3 2026, its #2961 holding.
- Stifel Financial first reported a position in ANI Pharmaceuticals in Q3 2017 and has held it in 17 quarters since.
- Stifel Financial's ANI Pharmaceuticals position peaked at $867K in Q2 2026.
- 291 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Stifel Financial's 13F filing for Q3 2026, filed 12 Nov 2026.